K241809 is an FDA 510(k) clearance for the coactiv+™ Antimicrobial Wound Gel. Classified as Dressing, Wound, Drug (product code FRO).
Submitted by Kane Biotech, Inc. (Winnipeg, CA). The FDA issued a Cleared decision on July 19, 2024 after a review of 28 days - a notably fast clearance cycle.
This device falls under the General & Plastic Surgery FDA review panel. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.
View all Kane Biotech, Inc. devices